Skip to main content

Soleno Therapeutics Inc

SLNODelisted May 18, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001484565

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Soleno Therapeutics Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SLNO: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4022−18
SharesConverted for a 1-for-15 split3.25M3.13M−124.4K (−3.8%)
Value$8.80M$5.23M−$3.57M (−40.6%)

New holders (3)

Institutions that held Soleno Therapeutics Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SLNO in Q3 2022
InstitutionSharesValue% of portfolio
Clayton Partners LLC100,000$167.0K0.19%
J. Goldman & Co LP44,999$75.0K0.01%
Morgan Stanley649$1.00K0.00%

Sold out (21)

Institutions that held Soleno Therapeutics Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of SLNO in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Oracle Investment Management Inc2,132,000$394.0K
Citadel Advisors LLC295,312$55.0K
Two Sigma Advisers, LP232,000$43.0K
Two Sigma Investments, LP149,546$28.0K
Northern Trust Corp105,481$20.0K
Commonwealth Equity Services, LLC100,000$18.0K
Oppenheimer & Co Inc98,054$18.0K
Warberg Asset Management LLC90,000$16.0K
Virtu Financial LLC67,569$12.0K
Aspiriant, LLC57,295$11.0K
UBS Group AG54,695$10.0K
Millennium Management LLC46,318$9.00K
Bank of New York Mellon Corp42,270$8.00K
HRT Financial LP47,726$8.00K
Onyx Bridge Wealth Group LLC20,000$4.00K
Susquehanna International Group, LLP16,843$3.00K
Avantax Planning Partners, Inc.10,700$2.00K
Two Sigma Securities, LLC12,724$2.00K
Levy Wealth Management Group, LLC10,000$2.00K
Citigroup Inc526$0
Cutler Group LP1,100$0